Basilea Pharmaceutica AG (OTCMKTS:BPMUF - Get Free Report) was the recipient of a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 3,600 shares, an increase of 3,500.0% from the March 31st total of 100 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 36.0 days. Approximately 0.0% of the company's stock are sold short.
Basilea Pharmaceutica Stock Performance
Basilea Pharmaceutica stock remained flat at $47.50 during trading hours on Thursday. The company has a current ratio of 4.10, a quick ratio of 3.27 and a debt-to-equity ratio of 5.70. The business's fifty day simple moving average is $52.26 and its 200 day simple moving average is $52.63. Basilea Pharmaceutica has a one year low of $47.50 and a one year high of $54.00.
Basilea Pharmaceutica Company Profile
(
Get Free Report)
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Read More
Before you consider Basilea Pharmaceutica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Basilea Pharmaceutica wasn't on the list.
While Basilea Pharmaceutica currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
